The customer, a syncardia certified hospital, reported that the patient died on (b)(6) 2020.The customer reported the cause of death as multi-organ system failure with worsening hypoxemic respiratory failure requiring v-v ecmo post tah-t implant.They also reported focal subarachnoid hemorrhage around the cerebellum and within the basal cisterns; death was distributive shock and hypoxemia in spite of v-v ecmo.The tah was explanted and an autopsy was performed on (b)(6) 2020.No further information has been provided at this time.
|
The explant analysis of the temporary total artificial heart evaluated the function of the diaphragms, the function and condition of the valves, as well as the overall condition of the heart.Visual inspection of the temporary total artificial heart found no anomalies or defects.No abnormalities or defects were found with the valves or the diaphragm.The diaphragm was visually inspected for any anomalies or defects, as well as tested for strength of stroke volume.Both the left and right ventricle diaphragms were free of defects, and both performed as intended during stroke volume testing.Scoring of the physical condition, functionality, and performance of the temporary total artificial heart determined that the temporary total artificial heart was functioning as intended while implanted, and there is no evidence of a device malfunction.This issue will be monitored and trended as part of the customer complaint process.Syncardia has completed its evaluation and is closing this file.(if new or additional information is received in the future, syncardia will file a follow-up mdr.) (b)(4) follow-up report 1.
|